Literature DB >> 21719744

A prospective study of bowel movement frequency and risk of Parkinson's disease.

Xiang Gao1, Honglei Chen, Michael A Schwarzschild, Alberto Ascherio.   

Abstract

The authors prospectively examined bowel movement frequency at baseline in relation to future Parkinson's disease risk in the Health Professionals Follow-up Study (HPFS) during 2000-2006 (33,901 men) and the Nurses' Health Study (NHS) during 1982-2006 (93,767 women). During the follow-up (6 years for the HPFS and 24 years for the NHS), the authors identified 156 incident male Parkinson's disease cases (HPFS) and 402 female cases (NHS). In the HPFS, compared with men with daily bowel movements, men with a bowel movement every 3 days or less had a multivariate-adjusted relative risk of 4.98 (95% confidence interval (CI): 2.59, 9.57) for developing Parkinson's disease in the next 6 years. In the NHS, the corresponding relative risk was 2.15 (95% CI: 0.76, 6.10), and the risk of Parkinson's disease was not elevated beyond 6 years of follow-up (relative risks = 1.25 for years 7-12, 0.54 for years 13-18, and 0.88 for years 19-24). When these 2 cohorts were combined, the pooled relative risks for Parkinson's disease in the next 6 years were 0.75, 1 (referent), 2.62, and 3.93 (95% CI: 2.26, 6.84) (P(trend) < 0.0001) across 4 bowel movement categories. In conclusion, infrequent bowel movements may antedate the onset of cardinal motor symptoms of Parkinson's disease and may contribute to the identification of populations with higher than average Parkinson's disease risk.

Entities:  

Mesh:

Year:  2011        PMID: 21719744      PMCID: PMC3202149          DOI: 10.1093/aje/kwr119

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  24 in total

1.  Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?

Authors:  R J Phillips; G C Walter; S L Wilder; E A Baronowsky; T L Powley
Journal:  Neuroscience       Date:  2008-03-18       Impact factor: 3.590

Review 2.  Parkinson's disease: the dual hit theory revisited.

Authors:  Christopher H Hawkes; Kelly Del Tredici; Heiko Braak
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

Review 3.  A timeline for Parkinson's disease.

Authors:  Christopher H Hawkes; Kelly Del Tredici; Heiko Braak
Journal:  Parkinsonism Relat Disord       Date:  2009-10-28       Impact factor: 4.891

4.  Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

Authors:  A Ascherio; S M Zhang; M A Hernán; I Kawachi; G A Colditz; F E Speizer; W C Willett
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422

5.  Medical records documentation of constipation preceding Parkinson disease: A case-control study.

Authors:  R Savica; J M Carlin; B R Grossardt; J H Bower; J E Ahlskog; D M Maraganore; A E Bharucha; W A Rocca
Journal:  Neurology       Date:  2009-11-24       Impact factor: 9.910

Review 6.  A review of the literature on gender and age differences in the prevalence and characteristics of constipation in North America.

Authors:  G Lindsay McCrea; Christine Miaskowski; Nancy A Stotts; Liz Macera; Madhulika G Varma
Journal:  J Pain Symptom Manage       Date:  2008-09-11       Impact factor: 3.612

7.  Gastrointestinal dysfunction in Parkinson's Disease.

Authors:  Wolfgang H Jost
Journal:  J Neurol Sci       Date:  2009-08-29       Impact factor: 3.181

Review 8.  A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.

Authors:  Kurt A Jellinger
Journal:  Biochim Biophys Acta       Date:  2008-08-05

9.  Perceived imbalance and risk of Parkinson's disease.

Authors:  Xiang Gao; Honglei Chen; Michael A Schwarzschild; Giancarlo Logroscino; Alberto Ascherio
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

10.  Bowel movement frequency in late-life and substantia nigra neuron density at death.

Authors:  Helen Petrovitch; Robert D Abbott; G Webster Ross; James Nelson; Kamal H Masaki; Caroline M Tanner; Lenore J Launer; Lon R White
Journal:  Mov Disord       Date:  2009-02-15       Impact factor: 10.338

View more
  36 in total

Review 1.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

2.  Individual and joint prevalence of three nonmotor symptoms of PD in the US general population.

Authors:  Honglei Chen; Xuemei Huang; Xuguang Guo; Shyamal Peddada
Journal:  Mov Disord       Date:  2014-07-01       Impact factor: 10.338

3.  Risk of Parkinson's disease after colectomy: longitudinal follow-up study using a national sample cohort.

Authors:  Young-Ju Kim; Chang-Min Lee; Seongheon Kim; Jae-Won Jang; Seo-Young Lee; Seung-Hwan Lee
Journal:  J Neurol       Date:  2019-11-05       Impact factor: 4.849

Review 4.  Viral and inflammatory triggers of neurodegenerative diseases.

Authors:  Michela Deleidi; Ole Isacson
Journal:  Sci Transl Med       Date:  2012-02-15       Impact factor: 17.956

Review 5.  Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord       Date:  2018-03       Impact factor: 10.338

6.  Parkinson's Disease-Related Motor and Nonmotor Symptoms in the Lancaster Amish.

Authors:  Michael D F Goldenberg; Xuemei Huang; Honglei Chen; Lan Kong; Teodor T Postolache; John W Stiller; Katherine A Ryan; Mary Pavlovich; Toni I Pollin; Alan R Shuldiner; Richard B Mailman; Braxton D Mitchell
Journal:  Neuroepidemiology       Date:  2020-07-31       Impact factor: 3.282

Review 7.  Parkinson's disease: Are gut microbes involved?

Authors:  Yogesh Bhattarai; Purna C Kashyap
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-09-02       Impact factor: 4.052

8.  Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease.

Authors:  Leo P Kelly; Paul M Carvey; Ali Keshavarzian; Kathleen M Shannon; Maliha Shaikh; Roy A E Bakay; Jeffrey H Kordower
Journal:  Mov Disord       Date:  2013-11-04       Impact factor: 10.338

Review 9.  Autonomic disorders predicting Parkinson's disease.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

10.  Declining quality of life in Parkinson disease before and after diagnosis.

Authors:  Natalia Palacios; Xiang Gao; Michael Schwarzschild; Alberto Ascherio
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.